Cairo-based on-demand medicine delivery platform has raised a seven-figure (USD) Pre-Series A, it announced today in a statement to MENAbytes without disclosing the exact size of the investment. The money came from 500 Startups (who are following-on), Vision Ventures, Womena, and few other investors. Chefaa had previously raised a six-figure seed from 500 Startups, Flat6Labs, and a few angel investors in August last year.
Founded in 2017 by Doaa Aref and CWI 2020 fellow Dr. Rasha Rady, Chefaa connects patients and pharmacies, enabling chronic patients to schedule, order, and refill their recurring prescriptions as well as other non-pharmaceutical products from pharmacies, through its web or mobile apps. The Egyptian startup claims to have fulfilled hundreds of thousands of orders to date.
Chefaa, serving as a marketplace, when a customer places an order, routes it to the nearest pharmacy who then delivers the medicines to the customers. It said in a statement that it is helping tens of thousands of chronic patients across Egypt to properly manage their treatment by enabling them to easily order their medicines on a regular basis. Chefaa focuses on chronic patients with repeat orders but its platform is also open for anyone with a prescription to order their medicines, whenever they need them.
The startup that has recently launched its private and white-label products as well now plans to use the investment to grow its operations team and launch its B2B service to serve SMEs.
Read more here.